Literature DB >> 6656176

[Individual heparin and protamine dosage in heart surgery].

D U Preiss, R Zobeley.   

Abstract

Several methods of heparin administration before and heparin neutralization after cardiopulmonary bypass (CPB) have been proposed, based on individual dose-response curves of the activated clotting time (ACT). We investigated the use of a regression line, established from simultaneous double determinations of the ACT before and after serial doses of heparin (240 and 360 IU/kg), calculated by computer to determine the doses of heparin and protamine needed. Administration of protamine doses calculated from ACT measurements at termination of CPB in 31 patients resulted in ACT measurements which were not significantly different from pre-heparin levels, however. ACT values after 360 IU/kg heparin varied widely. Among 351 patients studied 62.9% had ACT values greater than 450 s, 27,9% had ACT values between 450 and 350 s, and 9.1% had ACT values less than 350 s. Our studies produced an interesting finding. Mean ACT values of women after both doses of heparin were significantly smaller (p less than 0.0000) (359.7 +/- 6 s, n = 144 and 452.4 +/- 9 s, n = 160) than those of men (393.8 +/- 3.7 s, n = 501 and 501.0 +/- 5.1 s, n = 549).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6656176     DOI: 10.1007/BF01530842

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  5 in total

1.  Evaluation of tests used to monitor heparin therapy during extracorporeal circulation.

Authors:  M H Bull; W M Huse; B S Bull
Journal:  Anesthesiology       Date:  1975-09       Impact factor: 7.892

2.  Is protamine a clinically important anticoagulant? A negative answer.

Authors:  N Ellison; A J Ominsky; H Wollman
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

3.  Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.

Authors:  B S Bull; R A Korpman; W M Huse; B D Briggs
Journal:  J Thorac Cardiovasc Surg       Date:  1975-05       Impact factor: 5.209

4.  Identification of heparin resistance during cardiac and vascular surgery.

Authors:  C D Mabry; R C Read; B W Thompson; G D Williams; H J White
Journal:  Arch Surg       Date:  1979-02

5.  Predictors of bleeding during heparin therapy.

Authors:  A M Walker; H Jick
Journal:  JAMA       Date:  1980-09-12       Impact factor: 56.272

  5 in total
  1 in total

1.  Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique.

Authors:  D U Preiss; H Schmidt-Bleibtreu; P Berguson; G Metz
Journal:  Klin Wochenschr       Date:  1985-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.